GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
205 hedge funds and large institutions have $1.89B invested in Global Blood Therapeutics, Inc. in 2021 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 61 increasing their positions, 64 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
10% more funds holding
Funds holding: 187 → 205 (+18)
5% less repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 64
Holders
205
Holding in Top 10
7
Calls
$13.1M
Puts
$8.9M
Top Buyers
| 1 | +$48.3M | |
| 2 | +$37.4M | |
| 3 | +$25.2M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$22M |
| 5 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
+$14.4M |
Top Sellers
| 1 | -$62.3M | |
| 2 | -$31.6M | |
| 3 | -$28M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$23.1M |
| 5 |
CC
Casdin Capital
New York
|
-$17.6M |